174 related articles for article (PubMed ID: 29459273)
1. New antitumor anthra[2,3-b]furan-3-carboxamides: Synthesis and structure-activity relationship.
Tikhomirov AS; Lin CY; Volodina YL; Dezhenkova LG; Tatarskiy VV; Schols D; Shtil AA; Kaur P; Chueh PJ; Shchekotikhin AE
Eur J Med Chem; 2018 Mar; 148():128-139. PubMed ID: 29459273
[TBL] [Abstract][Full Text] [Related]
2. New anthra[2,3-b]furancarboxamides: A role of positioning of the carboxamide moiety in antitumor properties.
Volodina YL; Dezhenkova LG; Tikhomirov AS; Tatarskiy VV; Kaluzhny DN; Moisenovich AM; Moisenovich MM; Isagulieva AK; Shtil AA; Tsvetkov VB; Shchekotikhin AE
Eur J Med Chem; 2019 Mar; 165():31-45. PubMed ID: 30659997
[TBL] [Abstract][Full Text] [Related]
3. Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties.
Shchekotikhin AE; Dezhenkova LG; Tsvetkov VB; Luzikov YN; Volodina YL; Tatarskiy VV; Kalinina AA; Treshalin MI; Treshalina HM; Romanenko VI; Kaluzhny DN; Kubbutat M; Schols D; Pommier Y; Shtil AA; Preobrazhenskaya MN
Eur J Med Chem; 2016 Apr; 112():114-129. PubMed ID: 26890118
[TBL] [Abstract][Full Text] [Related]
4. Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.
Tikhomirov AS; Litvinova VA; Andreeva DV; Tsvetkov VB; Dezhenkova LG; Volodina YL; Kaluzhny DN; Treshalin ID; Schols D; Ramonova AA; Moisenovich MM; Shtil AA; Shchekotikhin AE
Eur J Med Chem; 2020 Aug; 199():112294. PubMed ID: 32428792
[TBL] [Abstract][Full Text] [Related]
5. Thiophene-2-carboxamide derivatives of anthraquinone: A new potent antitumor chemotype.
Volodina YL; Tikhomirov AS; Dezhenkova LG; Ramonova AA; Kononova AV; Andreeva DV; Kaluzhny DN; Schols D; Moisenovich MM; Shchekotikhin AE; Shtil AA
Eur J Med Chem; 2021 Oct; 221():113521. PubMed ID: 34082225
[TBL] [Abstract][Full Text] [Related]
6. The first series of 4,11-bis[(2-aminoethyl)amino]anthra[2,3-b]furan-5,10-diones: Synthesis and anti-proliferative characteristics.
Shchekotikhin AE; Glazunova VA; Dezhenkova LG; Shevtsova EK; Traven' VF; Balzarini J; Huang HS; Shtil AA; Preobrazhenskaya MN
Eur J Med Chem; 2011 Jan; 46(1):423-8. PubMed ID: 21144624
[TBL] [Abstract][Full Text] [Related]
7. Ring fusion strategy for synthesis and lead optimization of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as promising scaffold of antitumor agents.
Lee YR; Chen TC; Lee CC; Chen CL; Ahmed Ali AA; Tikhomirov A; Guh JH; Yu DS; Huang HS
Eur J Med Chem; 2015 Sep; 102():661-76. PubMed ID: 26344783
[TBL] [Abstract][Full Text] [Related]
8. Novel multi-targeting anthra[2,3-b]thiophene-5,10-diones with guanidine-containing side chains: interaction with telomeric G-quadruplex, inhibition of telomerase and topoisomerase I and cytotoxic properties.
Ilyinsky NS; Shchyolkina AK; Borisova OF; Mamaeva OK; Zvereva MI; Azhibek DM; Livshits MA; Mitkevich VA; Balzarini J; Sinkevich YB; Luzikov YN; Dezhenkova LG; Kolotova ES; Shtil AA; Shchekotikhin AE; Kaluzhny DN
Eur J Med Chem; 2014 Oct; 85():605-14. PubMed ID: 25127152
[TBL] [Abstract][Full Text] [Related]
9. Ring fusion strategy for the synthesis of anthra[2,3-d]oxazole-2-thione-5,10-dione homologues as DNA topoisomerase inhibitors and as antitumor agents.
Chen CL; Liu FL; Lee CC; Chen TC; Chang WW; Guh JH; Ahmed Ali AA; Chang DM; Huang HS
Eur J Med Chem; 2014 Nov; 87():30-8. PubMed ID: 25240093
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.
Dong G; Fang Y; Liu Y; Liu N; Wu S; Zhang W; Sheng C
Bioorg Med Chem Lett; 2017 May; 27(9):1929-1933. PubMed ID: 28351590
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
Teng CH; Won SJ; Lin CN
Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
[TBL] [Abstract][Full Text] [Related]
12. Anthraquinone derivatives induce G2/M cell cycle arrest and apoptosis in NTUB1 cells.
Tu HY; Huang AM; Teng CH; Hour TC; Yang SC; Pu YS; Lin CN
Bioorg Med Chem; 2011 Sep; 19(18):5670-8. PubMed ID: 21852140
[TBL] [Abstract][Full Text] [Related]
13. Bis(phenazine-1-carboxamides): structure-activity relationships for a new class of dual topoisomerase I/II-directed anticancer drugs.
Spicer JA; Gamage SA; Rewcastle GW; Finlay GJ; Bridewell DJ; Baguley BC; Denny WA
J Med Chem; 2000 Apr; 43(7):1350-8. PubMed ID: 10753472
[TBL] [Abstract][Full Text] [Related]
14. Natural product-based design, synthesis and biological evaluation of anthra[2,1-d]thiazole-6,11-dione derivatives from rhein as novel antitumour agents.
Liang YK; Yue ZZ; Li JX; Tan C; Miao ZH; Tan WF; Yang CH
Eur J Med Chem; 2014 Sep; 84():505-15. PubMed ID: 25050882
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxic properties of 4,11-bis[(aminoethyl)amino]anthra[2,3-b]thiophene-5,10-diones, novel analogues of antitumor anthracene-9,10-diones.
Shchekotikhin AE; Glazunova VA; Dezhenkova LG; Luzikov YN; Sinkevich YB; Kovalenko LV; Buyanov VN; Balzarini J; Huang FC; Lin JJ; Huang HS; Shtil AA; Preobrazhenskaya MN
Bioorg Med Chem; 2009 Mar; 17(5):1861-9. PubMed ID: 19208482
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of substituted indeno[1,2-b]quinoline-6-carboxamides, [1]benzothieno[3,2-b]quinoline-4-carboxamides and 10H-quindoline-4-carboxamides: evaluation of structure-activity relationships for cytotoxicity.
Chen J; Deady LW; Desneves J; Kaye AJ; Finlay GJ; Baguley BC; Denny WA
Bioorg Med Chem; 2000 Oct; 8(10):2461-6. PubMed ID: 11058041
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of substituted 11H-benzo[a]carbazole-5-carboxamides as novel antitumor agents.
Wang YQ; Li XH; He Q; Chen Y; Xie YY; Ding J; Miao ZH; Yang CH
Eur J Med Chem; 2011 Dec; 46(12):5878-84. PubMed ID: 22000922
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents.
Chen TC; Yu DS; Huang KF; Fu YC; Lee CC; Chen CL; Huang FC; Hsieh HH; Lin JJ; Huang HS
Eur J Med Chem; 2013 Nov; 69():278-93. PubMed ID: 24051300
[TBL] [Abstract][Full Text] [Related]
20. Novel angular benzophenazines: dual topoisomerase I and topoisomerase II inhibitors as potential anticancer agents.
Vicker N; Burgess L; Chuckowree IS; Dodd R; Folkes AJ; Hardick DJ; Hancox TC; Miller W; Milton J; Sohal S; Wang S; Wren SP; Charlton PA; Dangerfield W; Liddle C; Mistry P; Stewart AJ; Denny WA
J Med Chem; 2002 Jan; 45(3):721-39. PubMed ID: 11806724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
